Skip to main content

ASCPT 2025 Annual Meeting Main banner

Browse by Poster Title

Browse by Poster Title

Type here to filter the list

All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#

S
PII-014
SAFETY , TOLERABILITY, AND PHARMACOKINETICS OF SM17 IN HEALTHY VOLUNTEERS, A NOVEL IL-17 RECEPTOR B TARGETING ANTIBODY IN PHASE I DEVELOPMENT FOR THE TREATMENT OF ASTHMA

Favorite
PI-106
SAFETY AND PHARMACOKINETICS OF DF-003, A TARGETED, FIRST-IN-CLASS ALPHA-KINASE 1 INHIBITOR FOR TREATMENT OF THE RARE GENETIC DISEASE, ROSAH SYNDROME.

Favorite
PII-091
SAFETY, PHARMACODYNAMICS, AND PHARMACOKINETICS OF IN-115314, A NOVEL SELECTIVE JAK1 INHIBITOR, AFTER A SINGLE OR MULTIPLE ORAL ADMINISTRATION IN HEALTHY MALE PARTICIPANTS.

Favorite
PI-016
SELTOREXANT DOES NOT PROLONG THE QT INTERVAL: A PLACEBO- AND POSITIVE-CONTROLLED, SINGLE DOSE PHASE 1 STUDY IN HEALTHY ADULTS

Favorite
PT-009
SHORT-TERM PHARMACODYNAMIC EFFECTS OF CANAGLIFLOZIN IN HEALTHY AMISH VOLUNTEERS

Favorite
PWI-002
SHORT-TERM PHARMACODYNAMIC EFFECTS OF CANAGLIFLOZIN IN HEALTHY AMISH VOLUNTEERS

Favorite
PII-020
SIMILAR BIOAVAILABILITY OF SUBCUTANEOUS BEPIROVIRSEN WHEN DELIVERED FROM A VIAL OR PREFILLED SYRINGE FITTED WITH A SAFETY SYRINGE DEVICE IN HEALTHY ADULT PARTICIPANTS

Favorite
PII-103
SPATIALCNS-PBPK: AN R/SHINY WEB-BASED PLATFORM FOR PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF SPATIAL PHARMACOKINETICS IN THE HUMAN CENTRAL NERVOUS SYSTEM AND BRAIN TUMORS

Favorite
PII-038
STRATEGIC CONSIDERATIONS FOR TUMOR DYNAMICS MODELING IN EARLY DEVELOPMENT: LEARNINGS FROM AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE

Favorite
PII-108
STREAMLINING POTENCY ASSESSMENT OF TOPICAL CORTICOSTEROIDS USING VASOCONSTRICTOR ASSAY (VCA)

Favorite